Literature DB >> 11090837

Observations on the onset of torsade de pointes arrhythmias in the acquired long QT syndrome.

M A Vos1, B Gorenek, S C Verduyn, F F van der Hulst, J D Leunissen, L Dohmen, H J Wellens.   

Abstract

OBJECTIVE: Premature ectopic beats may create a specific sequence of events (e.g. short-long-short) preceding Torsade de Pointes arrhythmias (TdP) in the long QT syndrome. The relevance of this sequence for the initiation of TdP is not clear. In our dog model of TdP, interventricular dispersion (DeltaAPD=left-right ventricular monophasic action potential duration: APD) is associated with TdP, therefore we tested the hypothesis that the ectopic beats contributes to DeltaAPD.
METHODS: In 17 anaesthetized dogs with chronic AV-block, which showed spontaneous TdP after class III medication, APD was analyzed to 1. quantitate the alterations due to (multiple) ectopic beats on the left and right APD (measured with endocardial catheters) and 2. compare the DeltaAPD prior to the occurrence of premature beats (steady state) in dogs with non-sudden onset of TdP (n=10) and sudden onset TdP (n=7). Three phases were distinguished: phase 1: steady state beats prior to ectopic beats, phase II: the beat(s) belonging to the dynamic phase, and phase III: the beat causing TdP. Because the coupling interval of premature beats in this condition often falls within the APD, the DeltaAPD(50) was validated as an alternative for the previously applied DeltaAPD(100) (r=0.51, P<0.01).
RESULTS: In steady state (phase I) DeltaAPD(50) is longer in the sudden onset TdP (130+/-35 ms) as in the non-sudden onset TdP (65+/-40 ms). In the non-sudden TdP group the dynamic phase II contribute to the heterogeneity in APD, i.e. LV-APD increases more than RV-APD leading to a DeltaAPD(50) increase to 130+/-100 ms (P<0.01) just preceding TdP (phase III).
CONCLUSION: The synergism between ectopic beats (short-long-short sequence) and DeltaAPD create the circumstances for TdP initiation.

Entities:  

Mesh:

Year:  2000        PMID: 11090837     DOI: 10.1016/s0008-6363(00)00192-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.

Authors:  Tilmann Schober; Sabine Huke; Raghav Venkataraman; Oleksiy Gryshchenko; Dmytro Kryshtal; Hyun Seok Hwang; Franz J Baudenbacher; Björn C Knollmann
Journal:  Circ Res       Date:  2012-05-29       Impact factor: 17.367

Review 2.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.

Authors:  Attila S Farkas; László Rudas; Péter Makra; Norbert Csík; István Leprán; Tamás Forster; Miklós Csanády; Julius Gy Papp; András Varró; András Farkas
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Mode of onset of polymorphic ventricular tachycardia in acute myocardial infarction.

Authors:  Bulent Gorenek; Osman Cengiz; Gulmira Kudaiberdieva; Ilker Durak; Volkan Dogan; Binnur Yasar; Alparslan Birdane; Yuksel Cavusoglu; Necmi Ata
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

Review 5.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

6.  Mechanisms of Premature Ventricular Complexes Caused by QT Prolongation.

Authors:  Zhaoyang Zhang; Michael B Liu; Xiaodong Huang; Zhen Song; Zhilin Qu
Journal:  Biophys J       Date:  2020-12-15       Impact factor: 4.033

7.  Mechanisms of phase-3 early afterdepolarizations and triggered activities in ventricular myocyte models.

Authors:  Zhaoyang Zhang; Zhilin Qu
Journal:  Physiol Rep       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.